Notice: This company has been marked as potentially delisted and may not be actively trading. Range Cancer Therapeutics ETF (CNCR) Holdings Add Compare Share Share Holdings Stock AnalysisDividendHeadlinesHoldingsRatingsShort InterestTrends Top 50 CNCR HoldingsRankCompanyCurrent PriceWeightShares Held1GLUEMonte Rosa Therapeutics$8.49+1.7%2.13%29,7982IBRXImmunityBio$5.10+1.2%1.97%47,9843ZYMEZymeworks$14.29+4.5%1.83%13,3864RVMDRevolution Medicines$56.75-0.1%1.82%3,7605EXELExelixis$35.61+2.2%1.80%6,0966MRSNMersana Therapeutics$2.04+3.0%1.80%85,006 Get the Latest News and Ratings for CNCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter. 7ACLXArcellx$90.44+3.7%1.74%2,1758BMYBristol-Myers Squibb$58.87+1.1%1.65%3,3509DNAGinkgo Bioworks$7.17+8.8%1.65%26,88010GNLXGenelux$2.55+3.7%1.63%65,93011ELVNEnliven Therapeutics$24.54-3.4%1.57%7,48312MGNXMacroGenics$3.24+0.9%1.57%48,82313XNCRXencor$25.01+3.8%1.57%7,91814BPMCBlueprint Medicines$94.15-2.6%1.56%1,94015KPTIKaryopharm Therapeutics$0.85+9.0%1.54%218,79116REPLReplimune Group$14.93+35.1%1.54%16,01017ZNTLZentalis Pharmaceuticals$3.23+1.6%1.51%45,50618NRIXNurix Therapeutics$22.05-1.4%1.49%6,58319DAWNDay One Biopharmaceuticals$13.72+2.8%1.48%12,28620EXAIExscientia$4.841.48%33,09521RXRXRecursion Pharmaceuticals$5.70-0.9%1.47%25,18222CRBUCaribou Biosciences$2.02+2.0%1.45%82,49423SDGRSchrödinger$20.84+2.3%1.45%8,43224SWTXSpringWorks Therapeutics$39.02+7.5%1.45%4,70925HCMHUTCHMED$17.36-1.8%1.44%10,13126JANXJanux Therapeutics$50.31+8.2%1.44%3,35727AURAAura Biosciences$8.95-0.9%1.41%16,79728ERASErasca$2.70+3.8%1.41%59,38429ARVNArvinas$25.86+3.0%1.40%6,65930MRUSMerus$45.49+2.6%1.40%3,33631IMCRImmunocore$32.28+0.5%1.39%5,07532RPTXRepare Therapeutics$2.81-5.4%1.38%50,44133ACRVAcrivon Therapeutics$6.55+1.7%1.36%20,34834FHTXFoghorn Therapeutics$7.84+1.6%1.34%18,08535KYMRKymera Therapeutics$44.98+3.4%1.34%3,45436RCUSArcus Biosciences$14.70+2.9%1.32%9,90937NUVBNuvation Bio$2.81+3.7%1.32%54,54838STROSutro Biopharma$2.51-0.8%1.32%45,26039CMPXCompass Therapeutics$1.49+8.0%1.31%97,93140SNDXSyndax Pharmaceuticals$16.09+3.1%1.30%9,201Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link.41BCYCBicycle Therapeutics$20.54+1.4%1.28%6,70742CGEMCullinan Therapeutics$12.54+2.6%1.27%9,89143ALLOAllogene Therapeutics$2.21+4.7%1.26%60,67544BMEABiomea Fusion$6.44+0.9%1.26%20,98545YMABY-mAbs Therapeutics$10.41+3.1%1.26%12,87246LYELLyell Immunopharma$0.95+3.3%1.25%135,05047PGENPrecigen$0.901.25%167,49648VORVor Biopharma$0.79-1.3%1.25%165,80549IOVAIovance Biotherapeutics$8.55+3.8%1.23%17,07150GERNGeron$4.07+1.2%1.20%38,321 Geographic ExposureUnited States95.6%Netherlands2.3%Currency ExposureUSD100.1%Sector ExposureHealth Care32.0%Industry ExposureBiotechnology32.0%SubIndustry ExposureBiotechnology24.2%Pharmaceuticals2.7%Coupon Exposure4-60.8%Maturity Exposure5-100.8% Related Companies and Tools Related Companies JPMorgan Healthcare Leaders ETF Portfolio Horizon Kinetics Medical ETF Portfolio First Trust Nasdaq Pharmaceuticals ETF Portfolio ProShares UltraShort Nasdaq Biotechnology Portfolio Invesco Nasdaq Biotechnology ETF Portfolio F/m Emerald Life Sciences Innovation ETF Portfolio ProShares Ultra Nasdaq Biotechnology Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio VanEck Biotech ETF Portfolio This page (NASDAQ:CNCR) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Range Cancer Therapeutics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Range Cancer Therapeutics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
